about
Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and TreatmentTargeted immune therapy of ovarian cancerCardio-oncology in targeting the HER receptor family: the puzzle of different cardiotoxicities of HER2 inhibitors.Immunity and immune suppression in human ovarian cancer.Multi-parametric analysis reveals enhanced G2-phase arrest of an optimized anti-HER2 antibody to inhibit breast cancer.Molecular mechanisms of cardiotoxicity induced by ErbB receptor inhibitor cancer therapeuticsImpact of the putative cancer stem cell markers and growth factor receptor expression on the sensitivity of ovarian cancer cells to treatment with various forms of small molecule tyrosine kinase inhibitors and cytotoxic drugs.Precision medicine and personalized breast cancer: combination pertuzumab therapy.Monoclonal antibodies and antibody fragments: state of the art and future perspectives in the treatment of non-haematological tumors.The Role of the Immune System in Ovarian Cancer and Implications on Therapy.miRNA-150 downregulation promotes pertuzumab resistance in ovarian cancer cells via AKT activation.Ligand-based receptor tyrosine kinase partial agonists: New paradigm for cancer drug discovery?NRF2 Regulates HER1 Signaling Pathway to Modulate the Sensitivity of Ovarian Cancer Cells to Lapatinib and Erlotinib.
P2860
Q28066904-CC6EEE47-178A-46DA-B85E-A539F0300206Q28082828-9E62A5D6-9209-48C8-99CC-B553BD0EBD3DQ33352155-62EFD5C0-14D5-47DE-9551-D75B2B616E31Q35138135-4713D614-0DFC-4B9C-BC6B-55B5763BFA80Q36385800-E5BCF371-0EEC-4F37-A638-768A29653FE5Q36396421-12E1E050-9A40-4BC7-8DF9-7E1C1B154E16Q37337898-852AE8B6-A797-4952-A188-A46B4693E855Q37687975-5DBDAF71-7CDA-4862-82D8-E1941DF0566BQ37887819-AB9D367D-0419-43DA-8A39-989610A70D74Q38715211-BC8C9485-189C-4E33-9200-823095F89495Q38873436-F1685C0B-1E99-4B4F-A3DF-D4C8E903EC6CQ42050622-09BBE476-EC34-463A-9E8E-3E031DE5EFA6Q48095126-AAD33A05-7EEA-4E0C-877D-52EBD34082DF
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pertuzumab for the treatment of ovarian cancer.
@en
Pertuzumab for the treatment of ovarian cancer.
@nl
type
label
Pertuzumab for the treatment of ovarian cancer.
@en
Pertuzumab for the treatment of ovarian cancer.
@nl
prefLabel
Pertuzumab for the treatment of ovarian cancer.
@en
Pertuzumab for the treatment of ovarian cancer.
@nl
P2093
P2860
P1476
Pertuzumab for the treatment of ovarian cancer
@en
P2093
Dana Faratian
Peter Mullen
Simon P Langdon
Yoko Nagumo
P2860
P304
P356
10.1517/14712598.2010.487062
P407
P577
2010-07-01T00:00:00Z